Michael C. Joiner - Publications

Affiliations: 
Medical Physics Wayne State University, Detroit, MI, United States 
Area:
Radiation Physics, Medical Biophysics

180 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Valadie OG, Brown SL, Farmer K, Nagaraja TN, Cabral G, Shadaia S, Divine GW, Knight RA, Lee IY, Dolan J, Rusu S, Joiner MC, Ewing JR. Characterization of the Response of 9L and U-251N Orthotopic Brain Tumors to 3D Conformal Radiation Therapy. Radiation Research. PMID 36656561 DOI: 10.1667/RADE-22-00048.1  0.345
2020 Burmeister JW, Dominello MM, Tracey MW, Kacin SE, Joiner MC. Final Report from IBPRO: Impact of Multidisciplinary Collaboration on Research in Radiation Oncology. Radiation Research. 194: 188-190. PMID 32845993 DOI: 10.1667/Rade-20-00117.1  0.333
2020 Green M, Van Nest SJ, Soisson E, Huber K, Liao Y, McBride W, Dominello MM, Burmeister J, Joiner MC. Three discipline collaborative radiation therapy (3DCRT) special debate: We should treat all cancer patients with hypofractionation. Journal of Applied Clinical Medical Physics. 21: 7-14. PMID 32602186 DOI: 10.1002/Acm2.12954  0.364
2020 Shaikh MY, Burmeister J, Scott R, Kumaraswamy LK, Nalichowski A, Joiner MC. Dosimetric evaluation of incorporating the revised V4.0 calibration protocol for breast intraoperative radiotherapy with the INTRABEAM system. Journal of Applied Clinical Medical Physics. PMID 32039545 DOI: 10.1002/Acm2.12807  0.469
2020 Shaikh MY, Joiner MC, Nalichowski A, Kumaraswamy LK, Burmeister J. Evaluation of the dosimetric impact of manufacturing variations for the INTRABEAM x-ray source. Journal of Applied Clinical Medical Physics. PMID 31976605 DOI: 10.1002/Acm2.12809  0.311
2019 Shaikh MY, Nalichowski A, Joiner MC, Burmeister J. Dosimetric evaluation of the INTRABEAM system for breast intraoperative radiotherapy: A single-institution experience. Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists. PMID 31606269 DOI: 10.1016/J.Meddos.2019.09.002  0.404
2019 Howell K, Matuszak M, Maitz CA, Eisaman SH, Padilla L, Brown SL, Joiner MC, Dominello MM, Burmeister J. Three Discipline Collaborative Radiation Therapy (3DCRT) special debate: In the future, at least 20% of NIH funding for radiotherapy research should be allocated to non-oncologic applications. Journal of Applied Clinical Medical Physics. PMID 31573150 DOI: 10.1002/Acm2.12729  0.361
2019 Blakely EA, Faddegon B, Tinkle C, Bloch C, Dominello M, Griffin RJ, Joiner MC, Burmeister J. Three discipline collaborative radiation therapy (3DCRT) special debate: The United States needs at least one carbon ion facility. Journal of Applied Clinical Medical Physics. PMID 31573146 DOI: 10.1002/Acm2.12727  0.413
2019 Grassberger C, Huber K, Jacob NK, Green MD, Mahler P, Prisciandaro J, Dominello M, Joiner MC, Burmeister J. Three discipline collaborative radiation therapy (3DCRT) special debate: The single most important factor in determining the future of SBRT is immune response. Journal of Applied Clinical Medical Physics. PMID 31573143 DOI: 10.1002/Acm2.12728  0.344
2019 Carrier F, Liao Y, Mendenhall N, Guerrieri P, Todor D, Ahmad A, Dominello M, Joiner MC, Burmeister J. Three Discipline Collaborative Radiation Therapy (3DCRT) Special Debate: I would treat prostate cancer with proton therapy. Journal of Applied Clinical Medical Physics. PMID 31166085 DOI: 10.1002/Acm2.12621  0.324
2019 Kim L, Markovina S, Van Nest SJ, Eisaman S, Santanam L, Sullivan JM, Dominello M, Joiner MC, Burmeister J. Three discipline collaborative radiation therapy (3DCRT) special debate: Equipment development is stifling innovation in radiation oncology. Journal of Applied Clinical Medical Physics. PMID 31127693 DOI: 10.1002/Acm2.12620  0.399
2019 Soisson E, Guerrieri P, Balasubramanian S, Ahamad A, Moran JM, Joiner MC, Dominello M, Burmeister J. Three discipline collaborative radiation therapy special debate: All head and neck cancer patients with intact tumors/nodes should have scheduled adaptive replanning performed at least once during the course of radiotherapy. Journal of Applied Clinical Medical Physics. PMID 30983132 DOI: 10.1002/Acm2.12587  0.339
2019 Mohindra P, Sawant A, Griffin RJ, Lamichhane N, Vlashi E, Xu-Welliver M, Dominello M, Joiner MC, Burmeister J. Three discipline collaborative radiation therapy (3DCRT) special debate: I would treat all early-stage NSCLC patients with SBRT. Journal of Applied Clinical Medical Physics. PMID 30793828 DOI: 10.1002/Acm2.12545  0.343
2019 Braunstein S, Wang L, Newhauser W, Tenenholz T, Rong Y, van der Kogel A, Dominello M, Joiner MC, Burmeister J. Three discipline collaborative radiation therapy (3DCRT) special debate: The United States should build additional proton therapy facilities. Journal of Applied Clinical Medical Physics. PMID 30735613 DOI: 10.1002/Acm2.12537  0.316
2018 Burmeister JW, Tracey MW, Kacin SE, Dominello MM, Joiner MC. …of Radiation Oncology, Biology, and Physics. International Journal of Radiation Oncology, Biology, Physics. 100: 1289-1290. PMID 29722663 DOI: 10.1016/J.Ijrobp.2018.01.045  0.384
2018 Burmeister JW, Tracey MW, Kacin SE, Dominello MM, Joiner MC. Improving Research in Radiation Oncology through Interdisciplinary Collaboration. Radiation Research. PMID 29693501 DOI: 10.1016/J.Ijrobp.2018.07.1149  0.341
2017 Dominello MM, Fountain MD, Rothstein SE, Cannon AC, Abernathy LM, Hoogstra D, Chen W, Joiner MC, Hillman GG. Radiation injury to cardiac arteries and myocardium is reduced by soy isoflavones. Journal of Radiation Oncology. 6: 307-315. PMID 31824587 DOI: 10.1007/S13566-017-0301-Z  0.336
2017 Rodrigues-Moreira S, Moreno SG, Ghinatti G, Lewandowski D, Hoffschir F, Ferri F, Gallouet AS, Gay D, Motohashi H, Yamamoto M, Joiner MC, Gault N, Romeo PH. Low-Dose Irradiation Promotes Persistent Oxidative Stress and Decreases Self-Renewal in Hematopoietic Stem Cells. Cell Reports. 20: 3199-3211. PMID 28954235 DOI: 10.1016/J.Celrep.2017.09.013  0.372
2017 Joiner MC, Tracey MW, Kacin SE, Burmeister JW. IBPRO - A Novel Short-Duration Teaching Course in Advanced Physics and Biology Underlying Cancer Radiotherapy. Radiation Research. PMID 28328309 DOI: 10.1667/Rr14723.1  0.386
2017 Abernathy LM, Fountain MD, Joiner MC, Hillman GG. Innate Immune Pathways Associated with Lung Radioprotection by Soy Isoflavones. Frontiers in Oncology. 7: 7. PMID 28168165 DOI: 10.3389/Fonc.2017.00007  0.351
2017 Bishop M, Miller S, Joiner M, Sauve K, Burmeister J, Paximadis P. Obesity and Hypofractionated Prostate Radiotherapy: Evaluation of Body Mass Index Influence on Dose-Volume Plan Characteristics International Journal of Radiation Oncology*Biology*Physics. 99: E638-E639. DOI: 10.1016/J.Ijrobp.2017.06.2143  0.329
2016 Rakowski JT, Tucker MA, Snyder MG, Makar SP, Yudelev M, Burmeister J, Joiner MC. Extrapolation Ionization Chamber Dosimetry of Fluorescent X-Ray Energies from 4.5 to 19.6 keV. Radiation Research. PMID 27548518 DOI: 10.1667/Rr14384.1  0.371
2016 Zaki M, Xu Y, Joiner M, Kim H, Dominello M. Cervical osteoradionecrosis following accelerated fractionation radiation therapy for laryngeal cancer. Practical Radiation Oncology. PMID 27155762 DOI: 10.1016/J.Prro.2016.03.001  0.389
2015 Abernathy LM, Fountain MD, Rothstein SE, David JM, Yunker CK, Rakowski J, Lonardo F, Joiner MC, Hillman GG. Soy Isoflavones Promote Radioprotection of Normal Lung Tissue by Inhibition of Radiation-Induced Activation of Macrophages and Neutrophils. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 1703-12. PMID 26709479 DOI: 10.1097/Jto.0000000000000677  0.351
2015 Fountain MD, Abernathy LM, Lonardo F, Rothstein SE, Dominello MM, Yunker CK, Chen W, Gadgeel S, Joiner MC, Hillman GG. Radiation-Induced Esophagitis is Mitigated by Soy Isoflavones. Frontiers in Oncology. 5: 238. PMID 26557504 DOI: 10.3389/Fonc.2015.00238  0.411
2015 Dynlacht JR, Zeman EM, Held KD, Deye J, Vikram B, Joiner MC. Education and Training Needs in the Radiation Sciences: Problems and Potential Solutions. Radiation Research. PMID 26479274 DOI: 10.1667/Rr14199.1  0.333
2015 Joshi GS, Joiner MC, Tucker JD. Effects of low oxygen levels on G2-specific cytogenetic low-dose hyper-radiosensitivity in irradiated human cells. Environmental and Molecular Mutagenesis. 56: 545-55. PMID 25808121 DOI: 10.1002/Em.21948  0.365
2015 Seth I, Joiner MC, Tucker JD. Cytogenetic low-dose hyperradiosensitivity is observed in human peripheral blood lymphocytes. International Journal of Radiation Oncology, Biology, Physics. 91: 82-90. PMID 25442345 DOI: 10.1016/J.Ijrobp.2014.09.020  0.51
2015 Abernathy LM, Fountain MD, David JM, Yunker CK, Joiner MC, Hillman GG. Abstract 277: Radioprotection of lung tissue involves modulation of radiation-induced macrophage activation by soy isoflavones Cancer Research. 75: 277-277. DOI: 10.1158/1538-7445.Am2015-277  0.373
2014 Li X, Lee P, Ohri N, Joiner M, Kong F, Jackson A. TU-A-BRD-01: Outcomes of Hypofractionated Treatments - Initial Results of the WGSBRT. Medical Physics. 41: 445-446. PMID 28038149 DOI: 10.1118/1.4889232  0.392
2014 Joshi GS, Joiner MC, Tucker JD. Cytogenetic characterization of low-dose hyper-radiosensitivity in Cobalt-60 irradiated human lymphoblastoid cells. Mutation Research. 770: 69-78. PMID 25771872 DOI: 10.1016/J.Mrfmmm.2014.09.006  0.539
2014 Konski A, Meyer JE, Joiner M, Hall MJ, Philip P, Shields A, McSpadden E, Choi M, Adaire B, Duncan G, Meropol NJ, Cescon TP, Cohen SJ. Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 113: 35-40. PMID 25441058 DOI: 10.1016/J.Radonc.2014.08.014  0.439
2014 Seth I, Schwartz JL, Stewart RD, Emery R, Joiner MC, Tucker JD. Neutron exposures in human cells: bystander effect and relative biological effectiveness. Plos One. 9: e98947. PMID 24896095 DOI: 10.1371/Journal.Pone.0098947  0.471
2014 Hillman GG, Lonardo F, Hoogstra DJ, Rakowski J, Yunker CK, Joiner MC, Dyson G, Gadgeel S, Singh-Gupta V. Axitinib Improves Radiotherapy in Murine Xenograft Lung Tumors. Translational Oncology. PMID 24862536 DOI: 10.1016/J.Tranon.2014.04.002  0.331
2014 Bakhmutsky MV, Joiner MC, Jones TB, Tucker JD. Differences in cytogenetic sensitivity to ionizing radiation in newborns and adults. Radiation Research. 181: 605-16. PMID 24828110 DOI: 10.1667/Rr13598.1  0.38
2014 Dominello MM, Nalichowski A, Paximadis P, Kaufman I, McSpadden E, Joiner M, Miller S, Konski A. Limitations of the bowel bag contouring technique in the definitive treatment of cervical cancer. Practical Radiation Oncology. 4: e15-20. PMID 24621427 DOI: 10.1016/J.Prro.2013.04.003  0.308
2013 Xiao N, Kong F, Ryu S, Chetty I, Burmeister J, Joiner M, Jin J. SU-E-T-293: A Radiobiological Model Based Approach to Evaluate Brain Radiotherapy Fractionation Regimens. Medical Physics. 40: 271. PMID 28518549 DOI: 10.1118/1.4814727  0.332
2013 Tucker JD, Divine GW, Grever WE, Thomas RA, Joiner MC, Smolinski JM, Auner GW. Gene expression-based dosimetry by dose and time in mice following acute radiation exposure. Plos One. 8: e83390. PMID 24358280 DOI: 10.1371/Journal.Pone.0083390  0.451
2013 Hillman GG, Singh-Gupta V, Lonardo F, Hoogstra DJ, Abernathy LM, Yunker CK, Rothstein SE, Rakowski J, Sarkar FH, Gadgeel S, Konski AA, Joiner MC. Radioprotection of lung tissue by soy isoflavones. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 1356-64. PMID 24077456 DOI: 10.1097/Jto.0B013E3182A4713E  0.343
2013 Hillman GG, Singh-Gupta V, Hoogstra DJ, Abernathy L, Rakowski J, Yunker CK, Rothstein SE, Sarkar FH, Gadgeel S, Konski AA, Lonardo F, Joiner MC. Differential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 109: 117-25. PMID 24021346 DOI: 10.1016/J.Radonc.2013.08.015  0.346
2013 Tucker JD, Vadapalli M, Joiner MC, Ceppi M, Fenech M, Bonassi S. Estimating the lowest detectable dose of ionizing radiation by the cytokinesis-block micronucleus assay. Radiation Research. 180: 284-91. PMID 23931722 DOI: 10.1667/Rr3346.1  0.474
2013 Cheong HS, Seth I, Joiner MC, Tucker JD. Relationships among micronuclei, nucleoplasmic bridges and nuclear buds within individual cells in the cytokinesis-block micronucleus assay. Mutagenesis. 28: 433-40. PMID 23702692 DOI: 10.1093/Mutage/Get020  0.431
2013 Hillman GG, Singh-Gupta V, Hoogstra DJ, Abernathy L, Rakowski J, Yunker C, Sarkar FH, Konski AA, Lonardo F, Joiner MC. Abstract LB-358: Soy improves radiotherapy for lung tumors and mitigates radiation-induced injury to lung tissue. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-358  0.345
2013 Xiao N, Kong F, Chetty I, Burmeister J, Joiner M, Jin J. Toward Individualized Fractionation Schedule for Lung Cancer Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 87: S542. DOI: 10.1016/J.Ijrobp.2013.06.1433  0.365
2012 Bentzen SM, Dörr W, Gahbauer R, Howell RW, Joiner MC, Jones B, Jones DT, van der Kogel AJ, Wambersie A, Whitmore G. Bioeffect modeling and equieffective dose concepts in radiation oncology--terminology, quantities and units. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 105: 266-8. PMID 23157980 DOI: 10.1016/J.Radonc.2012.10.006  0.482
2012 Singh-Gupta V, Banerjee S, Yunker CK, Rakowski JT, Joiner MC, Konski AA, Sarkar FH, Hillman GG. B-DIM impairs radiation-induced survival pathways independently of androgen receptor expression and augments radiation efficacy in prostate cancer. Cancer Letters. 318: 86-92. PMID 22155105 DOI: 10.1016/J.Canlet.2011.12.006  0.375
2012 Tucker JD, Grever WE, Joiner MC, Konski AA, Thomas RA, Smolinski JM, Divine GW, Auner GW. Gene expression-based detection of radiation exposure in mice after treatment with granulocyte colony-stimulating factor and lipopolysaccharide. Radiation Research. 177: 209-19. PMID 22128785 DOI: 10.1667/Rr2749.1  0.362
2012 Snyder M, Burmeister J, Joiner M, Meyer J, Tait L, Cohen S, McSpadden E, Konski A. Potential Gender Differences in a Normal Tissue Complication Probability Model for Heart Toxicity During Radiation Therapy for Esophageal Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S757-S758. DOI: 10.1016/J.Ijrobp.2012.07.2026  0.356
2012 Hillman G, Singh-Gupta V, Hoogstra D, Yunker C, Abernathy L, Rakowski J, Sarkar F, Konski A, Lonardo F, Joiner M. Radioprotective Effects of Soy Isoflavones on Normal Lung Tissue Could Translate to Improve Radiation Therapy Outcome of Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S703. DOI: 10.1016/J.Ijrobp.2012.07.1880  0.32
2011 Hillman GG, Singh-Gupta V, Runyan L, Yunker CK, Rakowski JT, Sarkar FH, Miller S, Gadgeel SM, Sethi S, Joiner MC, Konski AA. Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injury. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 101: 329-36. PMID 22079530 DOI: 10.1016/J.Radonc.2011.10.020  0.372
2011 Joiner MC, Thomas RA, Grever WE, Smolinski JM, Divine GW, Konski AA, Auner GW, Tucker JD. Developing point of care and high-throughput biological assays for determining absorbed radiation dose. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 101: 233-6. PMID 21724286 DOI: 10.1016/J.Radonc.2011.05.068  0.452
2011 Snyder M, Joiner MC, Konski A, Bossenberger T, Burmeister J. Dose escalation in prostate cancer using intensity modulated neutron radiotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 99: 201-6. PMID 21620496 DOI: 10.1016/J.Radonc.2011.05.019  0.343
2011 Hillman GG, Singh-Gupta V, Al-Bashir AK, Yunker CK, Joiner MC, Sarkar FH, Abrams J, Haacke EM. Monitoring sunitinib-induced vascular effects to optimize radiotherapy combined with soy isoflavones in murine xenograft tumor. Translational Oncology. 4: 110-21. PMID 21461174 DOI: 10.1593/Tlo.10274  0.35
2011 Singh-Gupta V, Joiner MC, Runyan L, Yunker CK, Sarkar FH, Miller S, Gadgeel SM, Konski AA, Hillman GG. Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 688-98. PMID 21325978 DOI: 10.1097/Jto.0B013E31821034Ae  0.38
2011 Salminen EK, Kiel K, Ibbott GS, Joiner MC, Rosenblatt E, Zubizarreta E, Wondergem J, Meghzifene A. International Conference on Advances in Radiation Oncology (ICARO): outcomes of an IAEA meeting. Radiation Oncology (London, England). 6: 11. PMID 21294881 DOI: 10.1186/1748-717X-6-11  0.336
2011 Singh-Gupta V, Banerjee S, Sarkar F, Runyan L, Yunker C, Rakowski J, Joiner M, Konski A, Hillman G. B-DIM Inhibits Androgen Receptor Activation and Potentiates Radiation Effect in Hormone Refractory Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 81: S741. DOI: 10.1016/J.Ijrobp.2011.06.1224  0.304
2010 Joiner MC, Mogili N, Marples B, Burmeister J. Significant dose can be lost by extended delivery times in IMRT with x rays but not high-LET radiations. Medical Physics. 37: 2457-2465. PMID 28513910 DOI: 10.1118/1.3425792  0.372
2010 Zhao B, Joiner MC, Orton CG, Burmeister J. "SABER": A new software tool for radiotherapy treatment plan evaluation. Medical Physics. 37: 5586-92. PMID 21158270 DOI: 10.1118/1.3497152  0.303
2010 Krueger SA, Wilson GD, Piasentin E, Joiner MC, Marples B. The effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivity. International Journal of Radiation Oncology, Biology, Physics. 77: 1509-17. PMID 20637979 DOI: 10.1016/J.Ijrobp.2010.01.028  0.733
2010 Joiner MC, Mogili N, Marples B, Burmeister J. Significant dose can be lost by extended delivery times in IMRT with x rays but not high-LET radiations. Medical Physics. 37: 2457-65. PMID 20632556 DOI: 10.1118/1.3425792  0.473
2010 Huang Y, Joiner M, Zhao B, Liao Y, Burmeister J. Dose convolution filter: incorporating spatial dose information into tissue response modeling. Medical Physics. 37: 1068-74. PMID 20384242 DOI: 10.1118/1.3309440  0.438
2010 Shaikh M, Burmeister J, Joiner M, Pandya S, Zhao B, Liu Q. Biological effect of different IMRT delivery techniques: SMLC, DMLC, and helical tomotherapy. Medical Physics. 37: 762-70. PMID 20229886 DOI: 10.1118/1.3284369  0.454
2010 Shridhar R, Estabrook W, Yudelev M, Rakowski J, Burmeister J, Wilson GD, Joiner MC. Characteristic 8 keV X rays possess radiobiological properties of higher-LET radiation. Radiation Research. 173: 290-7. PMID 20199214 DOI: 10.1667/Rr1782.1  0.322
2010 Snyder M, Joiner M, Burmeister J. SU-GG-T-501: An RBE Rescaling Method for the Comparison of Intensity Modulated Neutron Radiotherapy Plans to Conventional Photon Intensity Modulated Radiotherapy Plans Medical Physics. 37: 3302-3302. DOI: 10.1118/1.3468897  0.353
2010 Zhao B, Joiner M, Burmeister J. SU-GG-T-488: SABER: A Software Tool Incorporating Spatial and Biological Information into Radiotherapy Treatment Planning Medical Physics. 37: 3299-3299. DOI: 10.1118/1.3468886  0.403
2010 Snyder M, Joiner M, Konski A, Bossenberger T, Burmeister J. Equivalent Radiobiological Dose Comparison between Photon IMRT and Intensity Modulated Neutron Radiotherapy International Journal of Radiation Oncology*Biology*Physics. 78: S808. DOI: 10.1016/J.Ijrobp.2010.07.1871  0.444
2010 Ahmad I, Singh-Gupta V, Yunker C, Burmeister J, Joiner M, Hillman G. Effect of Pre-treatment Imaging Dose on the Radiosensitivity of Tumor Cells International Journal of Radiation Oncology*Biology*Physics. 78: S732. DOI: 10.1016/J.Ijrobp.2010.07.1696  0.397
2010 Chen G, Kollar L, Paximadis P, Joiner M, Burmeister J, Gadgeel S, Wozniak A, Baciewicz F, Konski A. Salvage Fast Neutron Radiotherapy for Treatment of Refractory Non-small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 78: S504-S505. DOI: 10.1016/J.Ijrobp.2010.07.1179  0.303
2009 Shridhar R, Bolton S, Joiner MC, Forman JD. Dose escalation using a hypofractionated, intensity-modulated radiation therapy boost for localized prostate cancer: preliminary results addressing concerns of high or low alpha/beta ratio. Clinical Genitourinary Cancer. 7: E52-7. PMID 19815482 DOI: 10.3816/Cgc.2009.N.024  0.351
2009 Campbell JM, Wong CO, Muzik O, Marples B, Joiner M, Burmeister J. Early dose response to yttrium-90 microsphere treatment of metastatic liver cancer by a patient-specific method using single photon emission computed tomography and positron emission tomography. International Journal of Radiation Oncology, Biology, Physics. 74: 313-20. PMID 19362251 DOI: 10.1016/J.Ijrobp.2008.12.058  0.316
2009 Ryan LA, Seymour CB, Joiner MC, Mothersill CE. Radiation-induced adaptive response is not seen in cell lines showing a bystander effect but is seen in lines showing HRS/IRR response. International Journal of Radiation Biology. 85: 87-95. PMID 19205987 DOI: 10.1080/09553000802635062  0.401
2009 Shaikh M, Zhao B, Burmeister J, Liu Q, Pandya S, Joiner M. SU-FF-T-503: Biological Effect of Different IMRT Delivery Techniques: SMLC, DMLC and Helical TomoTherapy® Medical Physics. 36: 2639-2639. DOI: 10.1118/1.3182001  0.438
2009 Zhao B, Joiner M, Liu Q, Burmeister J. SU-EE-A2-01: Spatial Dose-Volume Histogram (sDVH) - Incorporating Spatial Dose Information Back Into the DVH Medical Physics. 36: 2429-2429. DOI: 10.1118/1.3181099  0.362
2009 Kumar T, Loren K, Holt J, Joiner M, Rakowski J. Inverse Planned Hybrid IMRT versus Field-in-Field (FINF) IMRT for Early Stage Breast Cancer: A Dosimetric Comparison and Preliminary Clinical Experience with Hybrid IMRT International Journal of Radiation Oncology*Biology*Physics. 75: S647. DOI: 10.1016/J.Ijrobp.2009.07.1476  0.428
2008 Liao Y, Joiner M, Huang Y, Burmeister J. TU-EE-A2-05: Hypofractionation: What Does It Mean For Prostate Cancer Treatment? Medical Physics. 35: 2911-2912. DOI: 10.1118/1.2962615  0.355
2008 Zhao B, Joiner M, Huang Y, Liao Y, Burmeister J. SU-GG-T-428: Incorporating Biological and Spatial Dose Information Can Change the Predicted Outcome of Radiotherapy Treatment Plans Medical Physics. 35: 2823-2823. DOI: 10.1118/1.2962176  0.451
2008 Marples B, Krueger S, Schoenherr D, Joiner M, Martinez A, Wilson G. Cell-cycle Checkpoint Control and Radiosensitivity after Low-dose X-irradiation: Implications for IMRT International Journal of Radiation Oncology*Biology*Physics. 72: S694. DOI: 10.1016/J.Ijrobp.2008.06.591  0.735
2008 Shridhar R, Yudelev M, Makar S, Burmeister J, Rakowski J, Estabrook W, Wilson G, Gutman G, Joiner M. Characteristic 8 Kev X-rays Possess Biological Properties of High LET Radiation International Journal of Radiation Oncology*Biology*Physics. 72: S705. DOI: 10.1016/J.Ijrobp.2008.06.529  0.374
2008 Marples B, Krueger SA, Collis SJ, Joiner MC. Low dose hyper-radiosensitivity: A historical perspective Targeted Radionuclide Tumor Therapy: Biological Aspects. 329-347. DOI: 10.1007/978-1-4020-8696-0_19  0.718
2007 Krueger SA, Collis SJ, Joiner MC, Wilson GD, Marples B. Transition in survival from low-dose hyper-radiosensitivity to increased radioresistance is independent of activation of ATM Ser1981 activity. International Journal of Radiation Oncology, Biology, Physics. 69: 1262-71. PMID 17967316 DOI: 10.1016/J.Ijrobp.2007.08.012  0.723
2007 Sgouros G, Knox SJ, Joiner MC, Morgan WF, Kassis AI. MIRD continuing education: Bystander and low dose-rate effects: are these relevant to radionuclide therapy? Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 1683-91. PMID 17873139 DOI: 10.2967/Jnumed.105.028183  0.534
2007 Krueger SA, Joiner MC, Weinfeld M, Piasentin E, Marples B. Role of apoptosis in low-dose hyper-radiosensitivity. Radiation Research. 167: 260-7. PMID 17316076 DOI: 10.1667/Rr0776.1  0.754
2007 Huang Y, Joiner M, Liao Y, Burmeister J. SU-GG-AUD-02: Dose Convolution Filter: Incorporating Spatial Dose Information Into Tissue Response Modeling Medical Physics. 34: 2506-2506. DOI: 10.1118/1.2761178  0.387
2006 Wykes SM, Piasentin E, Joiner MC, Wilson GD, Marples B. Low-dose hyper-radiosensitivity is not caused by a failure to recognize DNA double-strand breaks. Radiation Research. 165: 516-24. PMID 16669705 DOI: 10.1667/Rr3553.1  0.453
2006 White J, Joiner MC. Toxicity from radiation in breast cancer. Cancer Treatment and Research. 128: 65-109. PMID 16335014 DOI: 10.1007/0-387-25354-8_5  0.345
2006 Greco O, Joiner MC, Doleh A, Powell AD, Hillman GG, Scott SD. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer. Gene Therapy. 13: 206-15. PMID 16307003 DOI: 10.1038/Sj.Gt.3302640  0.338
2006 Mogili N, Joiner M, Burmeister J. TH-E-230A-02: Effects of IMRT Treatment Time Prolongation On Tumor Cell Survival Medical Physics. 33: 2294-2294. DOI: 10.1118/1.2241964  0.474
2006 Srinivasan M, Yudelev M, Gutman G, Burmeister J, Lyons K, Joiner M. TH-C-224C-01: Relative Biological Effectiveness(RBE) and Dosimetry of Low Energy Photons(8keV) Generated Using Miniature X-Ray Tubes Medical Physics. 33: 2273-2273. DOI: 10.1118/1.2241874  0.396
2006 Joiner M, Krueger S, Wilson G, Marples B. 41 Low-dose hypersensitivity: Biological mechanism Radiotherapy and Oncology. 78: S15. DOI: 10.1016/S0167-8140(06)80535-9  0.723
2005 Krause M, Wohlfarth J, Georgi B, Pimentel N, Dorner D, Zips D, Eicheler W, Hessel F, Short SC, Joiner MC, Baumann M. Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo. International Journal of Radiation Biology. 81: 751-8. PMID 16449082 DOI: 10.1080/09553000500491537  0.441
2005 Krause M, Prager J, Wohlfarth J, Hessel F, Dorner D, Haase M, Joiner MC, Baumann M. Ultrafractionation does not improve the results of radiotherapy in radioresistant murine DDL1 lymphoma. Strahlentherapie Und Onkologie : Organ Der Deutschen RöNtgengesellschaft ... [Et Al]. 181: 540-4. PMID 16044223 DOI: 10.1007/S00066-005-1396-5  0.494
2005 Greco O, Powell TM, Marples B, Joiner MC, Scott SD. Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin. Cancer Gene Therapy. 12: 655-62. PMID 15818381 DOI: 10.1038/Sj.Cgt.7700834  0.369
2005 Marples B, Greco O, Joiner MC, Scott SD. Radiogenetic Therapy Using Radiation-Responsive Gene Promoters Frontiers in Medicinal Chemistry - Online. 2: 317-330. DOI: 10.2174/1567204052931168  0.356
2004 Harney J, Short SC, Shah N, Joiner M, Saunders MI. Low dose hyper-radiosensitivity in metastatic tumors. International Journal of Radiation Oncology, Biology, Physics. 59: 1190-5. PMID 15234055 DOI: 10.1016/J.Ijrobp.2003.12.029  0.498
2004 Harney J, Shah N, Short S, Daley F, Groom N, Wilson GD, Joiner MC, Saunders MI. The evaluation of low dose hyper-radiosensitivity in normal human skin. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 70: 319-29. PMID 15064019 DOI: 10.1016/J.Radonc.2004.01.015  0.495
2004 Marples B, Wouters BG, Collis SJ, Chalmers AJ, Joiner MC. Low-dose hyper-radiosensitivity: a consequence of ineffective cell cycle arrest of radiation-damaged G2-phase cells. Radiation Research. 161: 247-55. PMID 14982490 DOI: 10.1667/Rr3130  0.54
2004 Joiner MC. A simple alpha/beta-independent method to derive fully isoeffective schedules following changes in dose per fraction. International Journal of Radiation Oncology, Biology, Physics. 58: 871-5. PMID 14967444 DOI: 10.1016/J.Ijrobp.2003.10.036  0.436
2004 Chalmers A, Johnston P, Woodcock M, Joiner M, Marples B. PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation. International Journal of Radiation Oncology, Biology, Physics. 58: 410-9. PMID 14751510 DOI: 10.1016/J.Ijrobp.2003.09.053  0.528
2004 Joiner M. New frontiers or red herrings in radiation oncology? The Lancet. Oncology. 5: 10. PMID 14700603 DOI: 10.1016/S1470-2045(03)01318-4  0.393
2004 Joiner MC. Introduction: Basic radiation research into the new millennium Cancer and Metastasis Reviews. 23: 193-195. DOI: 10.1023/B:Canc.0000031760.17131.17  0.371
2004 Greco O, Marples B, Joiner MC, Wilson GD, Scott SD. 962. Hypoxia- and Radiation-Activated Cre/loxP Molecular Switch Vectors for Gene Therapy of Solid Tumors Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.905  0.315
2003 Coleman CN, Stone HB, Alexander GA, Barcellos-Hoff MH, Bedford JS, Bristow RG, Dynlacht JR, Fuks Z, Gorelic LS, Hill RP, Joiner MC, Liu FF, McBride WH, McKenna WG, Powell SN, et al. Education and training for radiation scientists: radiation research program and American Society of Therapeutic Radiology and Oncology Workshop, Bethesda, Maryland, May 12-14, 2003. Radiation Research. 160: 729-37. PMID 14640790 DOI: 10.1667/Rr3096  0.404
2003 Marples B, Greco O, Joiner MC, Scott SD. Radiogenetic therapy: strategies to overcome tumor resistance. Current Pharmaceutical Design. 9: 2105-12. PMID 14529408 DOI: 10.2174/1381612033454090  0.355
2003 Krause M, Hessel F, Wohlfarth J, Zips D, Hoinkis C, Foest H, Petersen C, Short SC, Joiner MC, Baumann M. Ultrafractionation in A7 human malignant glioma in nude mice. International Journal of Radiation Biology. 79: 377-83. PMID 12963539 DOI: 10.1080/0955300031000140775  0.329
2003 Marples B, Wouters BG, Joiner MC. An association between the radiation-induced arrest of G2-phase cells and low-dose hyper-radiosensitivity: a plausible underlying mechanism? Radiation Research. 160: 38-45. PMID 12816521 DOI: 10.1667/Rr3013  0.397
2003 Short SC, Woodcock M, Marples B, Joiner MC. Effects of cell cycle phase on low-dose hyper-radiosensitivity International Journal of Radiation Biology. 79: 99-105. DOI: 10.1080/713865036  0.445
2003 Short SC, Woodcock M, Marples B, Joiner MC. Effects of cell cycle phase on low-dose hyper-radiosensitivity International Journal of Radiation Biology. 79: 99-105. DOI: 10.1080/0955300021000045646  0.337
2002 Marples B, Cann NE, Mitchell CR, Johnston PJ, Joiner MC. Evidence for the involvement of DNA-dependent protein kinase in the phenomena of low dose hyper-radiosensitivity and increased radioresistance. International Journal of Radiation Biology. 78: 1139-47. PMID 12556341 DOI: 10.1080/09553000210166606  0.403
2002 Mitchell CR, Joiner MC. Effect of subsequent acute-dose irradiation on cell survival in vitro following low dose-rate exposures. International Journal of Radiation Biology. 78: 981-90. PMID 12456285 DOI: 10.1080/0955300021006589  0.525
2002 Scott SD, Joiner MC, Marples B. Optimizing radiation-responsive gene promoters for radiogenetic cancer therapy. Gene Therapy. 9: 1396-402. PMID 12365005 DOI: 10.1038/Sj.Gt.3301822  0.371
2002 Mitchell CR, Folkard M, Joiner MC. Effects of exposure to low-dose-rate (60)co gamma rays on human tumor cells in vitro. Radiation Research. 158: 311-8. PMID 12175308 DOI: 10.1667/0033-7587(2002)158[0311:Eoetld]2.0.Co;2  0.506
2002 Mothersill C, Seymour CB, Joiner MC. Relationship between radiation-induced low-dose hypersensitivity and the bystander effect. Radiation Research. 157: 526-32. PMID 11966318 DOI: 10.1667/0033-7587(2002)157[0526:Rbrild]2.0.Co;2  0.55
2002 Marples B, Greco O, Joiner MC, Scott SD. Molecular approaches to chemo-radiotherapy. European Journal of Cancer (Oxford, England : 1990). 38: 231-9. PMID 11803140 DOI: 10.1016/S0959-8049(01)00367-7  0.402
2001 Short SC, Kelly J, Mayes CR, Woodcock M, Joiner MC. Low-dose hypersensitivity after fractionated low-dose irradiation in vitro. International Journal of Radiation Biology. 77: 655-64. PMID 11403705 DOI: 10.1080/09553000110041326  0.542
2001 Aird EG, Folkard M, Mayes CR, Bownes PJ, Lawson JM, Joiner MC. A purpose-built iodine-125 irradiation plaque for low dose rate low energy irradiation of cell lines in vitro. The British Journal of Radiology. 74: 56-61. PMID 11227778 DOI: 10.1259/Bjr.74.877.740056  0.511
2001 Barber PR, Vojnovic B, Kelly J, Mayes CR, Boulton P, Woodcock M, Joiner MC. Automated counting of mammalian cell colonies. Physics in Medicine and Biology. 46: 63-76. PMID 11197679 DOI: 10.1088/0031-9155/46/1/305  0.379
2001 Joiner MC, Marples B, Lambin P, Short SC, Turesson I. Low-dose hypersensitivity: current status and possible mechanisms. International Journal of Radiation Oncology, Biology, Physics. 49: 379-89. PMID 11173131 DOI: 10.1016/S0360-3016(00)01471-1  0.521
2001 Baumann M, Bentzen SM, Doerr W, Joiner MC, Saunders M, Tannock IF, Thames HD. The translational research chain: is it delivering the goods? International Journal of Radiation Oncology, Biology, Physics. 49: 345-51. PMID 11173127 DOI: 10.1016/S0360-3016(00)01483-8  0.355
2001 Joiner M, Short S, Marples B, Saunders M. Low dose hyper-radiosensitivity European Journal of Cancer. 37: S136-S137. DOI: 10.1016/S0959-8049(01)80993-X  0.5
2000 Robson T, Price ME, Moore ML, Joiner MC, McKelvey-Martin VJ, McKeown SR, Hirst DG. Increased repair and cell survival in cells treated with DIR1 antisense oligonucleotides: implications for induced radioresistance. International Journal of Radiation Biology. 76: 617-23. PMID 10866283 DOI: 10.1080/095530000138277  0.313
2000 Marples B, Joiner MC. Modification of survival by DNA repair modifiers: A probable explanation for the phenomenon of increased radioresistance International Journal of Radiation Biology. 76: 305-312. PMID 10757310 DOI: 10.1080/095530000138646  0.411
1999 Short SC, Mitchell SA, Boulton P, Woodcock M, Joiner MC. The response of human glioma cell lines to low-dose radiation exposure International Journal of Radiation Biology. 75: 1341-1348. PMID 10597908 DOI: 10.1080/095530099139214  0.522
1999 Robson T, Joiner MC, Wilson GD, McCullough W, Price ME, Logan I, Jones H, McKeown SR, Hirst DG. A novel human stress response-related gene with a potential role in induced radioresistance. Radiation Research. 152: 451-61. PMID 10521921 DOI: 10.2307/3580140  0.389
1999 Short S, Mayes C, Woodcock M, Johns H, Joiner MC. Low dose hypersensitivity in the T98G human glioblastoma cell line. International Journal of Radiation Biology. 75: 847-55. PMID 10489896 DOI: 10.1080/095530099139908  0.434
1999 Joiner MC, Lambin P, Marples B. Adaptive response and induced resistance Comptes Rendus De L'Academie Des Sciences - Serie Iii. 322: 167-175. PMID 10196669 DOI: 10.1016/S0764-4469(99)80040-7  0.54
1999 Saunders M, Shah N, Joiner M. 1020 Low dose hyper-radiosensitivity — Is it a clinical reality and can it influence the radiation schedules used in the treatment of gliomas? International Journal of Radiation Oncology*Biology*Physics. 45: 267-268. DOI: 10.1016/S0360-3016(99)90246-8  0.499
1998 Short SC, Joiner MC. Cellular response to low-dose irradiation Clinical Oncology. 10: 73-77. PMID 9610894 DOI: 10.1016/S0936-6555(05)80480-7  0.496
1997 Adams GE, Hasan NM, Joiner MC. The Klaas Breur Lecture. Radiation, hypoxia and genetic stimulation: implications for future therapies. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 44: 101-9. PMID 9288838 DOI: 10.1016/S0167-8140(97)00090-X  0.469
1997 Robson TA, Lohrer H, Bailie JR, Hirst DG, Joiner MC, Arrand JE. Gene regulation by low-dose ionizing radiation in a normal human lung epithelial cell line. Biochemical Society Transactions. 25: 335-42. PMID 9056895 DOI: 10.1042/Bst0250335  0.47
1996 Joiner MC, Lambin P, Malaise EP, Robson T, Arrand JE, Skov KA, Marples B. Hypersensitivity to very-low single radiation doses: Its relationship to the adaptive response and induced radioresistance Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 358: 171-183. PMID 8946022 DOI: 10.1016/S0027-5107(96)00118-2  0.531
1996 Turesson I, Joiner MC. Clinical evidence of hypersensitivity to low doses in radiotherapy Radiotherapy and Oncology. 40: 1-3. PMID 8844882 DOI: 10.1016/0167-8140(96)01765-3  0.506
1996 Rojas A, Vojnovic B, Johns H, Joiner MC, Martindale C, Fowler JF, Denekamp J. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: Therapeutic gain comparisons for fractionated x-ray schedules Radiotherapy and Oncology. 39: 53-64. PMID 8735494 DOI: 10.1016/0167-8140(95)01678-3  0.349
1996 Rojas A, Denekamp J, Johns H, Kjellen E, Tsang R, Nilsson P, Stratford MRL, Dennis MF, Joiner MC. Nicotinamide as a repair inhibitor in vivo: Studies using single and fractionated X-ray doses in mouse skin and kidneys Radiation Research. 145: 419-431. PMID 8600502 DOI: 10.2307/3579063  0.469
1996 Lambin P, Joiner M. 558Could radioresistant tumours be tackled with “ultrafractionation” using doses per fraction <0·5 Gy? Radiotherapy and Oncology. 40: S143. DOI: 10.1016/S0167-8140(96)80567-6  0.371
1995 Johns H, Morris WJ, Joiner MC. Radiation response of murine eccrine sweat glands. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 36: 56-64. PMID 8525026 DOI: 10.1016/0167-8140(95)01560-4  0.49
1995 Marples B, Joiner MC. The elimination of low-dose hypersensitivity in Chinese hamster V79-379A cells by pretreatment with X rays or hydrogen peroxide. Radiation Research. 141: 160-9. PMID 7838954 DOI: 10.2307/3579043  0.468
1995 Judas L, Bentzen SM, Johns H, Joiner MC, Morris WJ. Time evolution of the number of functional murine eccrine sweat glands after irradiation: a quantitative analysis of experimental data using a model of proliferative and functional organization. International Journal of Radiation Biology. 67: 565-75. PMID 7775832 DOI: 10.1080/09553009514550681  0.388
1994 Stevens G, Hill SA, Joiner MC, Joiner B, Johns H, Williams K, Denekamp J, Nethersell ABW. The effect of BW12C on the radiosensitivity and necrosis of murine tissues and tumours Australasian Radiology. 38: 199-203. PMID 7945114 DOI: 10.1111/J.1440-1673.1994.Tb00174.X  0.386
1994 Lambin P, Malaise EP, Joiner MC. The effect of very low radiation doses on the human bladder carcinoma cell line RT112 Radiotherapy and Oncology. 32: 63-72. PMID 7938680 DOI: 10.1016/0167-8140(94)90450-2  0.489
1994 Singh B, Arrand JE, Joiner MC. Hypersensitive response of normal human lung epithelial cells at low radiation doses International Journal of Radiation Biology. 65: 457-464. PMID 7908933 DOI: 10.1080/09553009414550531  0.537
1994 Joiner MC. Induced radioresistance: An overview and historical perspective International Journal of Radiation Biology. 65: 79-84. PMID 7905914 DOI: 10.1080/09553009414550111  0.486
1994 Lambin P, Fertil B, Malaise EP, Joiner MC. Multiphasic Survival Curves for Cells of Human Tumor Cell Lines: Induced Repair or Hypersensitive Subpopulation? Radiation Research. 138: S32. DOI: 10.2307/3578756  0.444
1994 Malaise EP, Lambin P, Joiner MC. Radiosensitivity of Human Cell Lines to Small Doses. Are There Some Clinical Implications? Radiation Research. 138: S25. DOI: 10.2307/3578754  0.395
1994 Joiner MC. Evidence for Induced Radioresistance from Survival and Other End Points: An Introduction Radiation Research. 138: S5. DOI: 10.2307/3578749  0.498
1994 Harris EE, Joiner MC, McKenna W. Use of mRNA differential. display to identify changes in gene expression in ht29 human tumor cells after exposure to low doses of ionizing radiation International Journal of Radiation Oncology*Biology*Physics. 30: 314. DOI: 10.1016/0360-3016(94)90898-2  0.416
1993 Joiner MC, Marples B, Johns H. The response of tissues to very low doses per fraction: a reflection of induced repair? Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 130: 27-40. PMID 8362097 DOI: 10.1007/978-3-642-84892-6_3  0.543
1993 Lambin P, Marples B, Fertil B, Malaise EP, Joiner MC. Hypersensitivity of a human tumour cell line to very low radiation doses International Journal of Radiation Biology. 63: 639-650. PMID 8099110 DOI: 10.1080/09553009314450831  0.5
1993 Marples B, Joiner MC. The Response of Chinese Hamster V79 Cells to Low Radiation Doses: Evidence of Enhanced Sensitivity of the Whole Cell Population Radiation Research. 133: 41. DOI: 10.2307/3578255  0.531
1993 Joiner MC, Rojas A, Johns H. Renal Damage in the Mouse: Repair Kinetics at 2 and 7 Gy per Fraction Radiation Research. 134: 355. DOI: 10.2307/3578197  0.447
1992 Rojas A, Joiner MC, Hodgkiss RJ, Carl U, Kjellen E, Wilson GD. Enhancement of tumor radiosensitivity and reduced hypoxia-dependent binding of a 2-nitroimidazole with normobaric oxygen and carbogen: a therapeutic comparison with skin and kidneys. International Journal of Radiation Oncology, Biology, Physics. 23: 361-6. PMID 1587757 DOI: 10.1016/0360-3016(92)90754-6  0.311
1992 Joiner MC, Rojas A, Johns H. A test of equal effect per fraction in the kidney of the mouse Radiation Research. 130: 227-235. PMID 1574579 DOI: 10.2307/3578280  0.428
1992 Stratford MRL, Rojas A, Hall DW, Dennis MF, Dische S, Joiner MC, Hodgkiss RJ. Pharmacokinetics of nicotinamide and its effect on blood pressure, pulse and body temperature in normal human volunteers Radiotherapy and Oncology. 25: 37-42. PMID 1410588 DOI: 10.1016/0167-8140(92)90193-X  0.388
1991 Stevens G, Joiner M, Joiner B, Johns H, Denekamp J. Early detection of damage following bilateral renal irradiation in the mouse. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 20: 124-31. PMID 1903208 DOI: 10.1016/0167-8140(91)90146-8  0.409
1991 Kjellen E, Joiner MC, Collier JM, Johns H, Rojas A. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 22: 81-91. PMID 1835542 DOI: 10.1016/0167-8140(91)90002-X  0.331
1991 Johns H, Joiner MC. A simple method for fitting curves to dose-effect data for functional damage. International Journal of Radiation Biology. 60: 533-41. PMID 1679092 DOI: 10.1080/09553009114552371  0.466
1991 Rojas A, Joiner MC, Johns H. Recovery kinetics of X-ray damage in mouse skin: the influence of dose per fraction. International Journal of Radiation Biology. 59: 517-36. PMID 1671700 DOI: 10.1080/09553009114550461  0.503
1991 Tsang RW, Joiner MC, Rojas A, Johns H. Repopulation in Murine Skin after X-Ray Treatments with Multiple Fractions per Day Radiation Research. 125: 163. DOI: 10.2307/3577884  0.319
1990 Rojas A, Joiner MC, Johns H. Recovery kinetics in mouse skin and CaNT tumours. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 16: 211-20. PMID 2587811 DOI: 10.1016/0167-8140(89)90021-2  0.329
1990 Field SB, Joiner MC. Expression of dose in neutron therapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 17: 73-80. PMID 2108477 DOI: 10.1016/0167-8140(90)90050-7  0.475
1990 Joiner MC, Rojas A, Michael BD. The influence of experimental design and data analysis on the determination of recovery kinetics of radiation damage between acute dose-rate treatments in vivo. International Journal of Radiation Biology. 57: 143-62. PMID 1967286 DOI: 10.1080/09553009014550411  0.501
1990 Nilsson P, Thames HD, Joiner MC. A generalized formulation of the 'incomplete-repair' model for cell survival and tissue response to fractionated low dose-rate irradiation. International Journal of Radiation Biology. 57: 127-42. PMID 1967284 DOI: 10.1080/09553009014550401  0.472
1989 Joiner MC. A comparison of the effects of p(62)-Be and d(16)-Be neutrons in the mouse kidney. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 13: 211-24. PMID 3222466 DOI: 10.1016/0167-8140(88)90058-8  0.475
1989 Rojas A, Joiner MC. The influence of dose per fraction on repair kinetics Radiotherapy and Oncology. 14: 329-336. PMID 2727319 DOI: 10.1016/0167-8140(89)90145-X  0.438
1989 Fowler JF, Whitsed CA, Joiner MC. Repair kinetics in mouse lung: a fast component at 1.1 Gy per fraction. International Journal of Radiation Biology. 56: 335-53. PMID 2570819 DOI: 10.1080/09553008914551501  0.469
1989 Joiner MC, Rojas A, Johns H. Does the repair capacity of skin change with repeated exposure to X-rays? International Journal of Radiation Biology. 55: 993-1005. PMID 2567336 DOI: 10.1080/09553008914551021  0.423
1988 Joiner MC, Field SB. The response of mouse skin to irradiation with neutrons from the 62 MV cyclotron at Clatterbridge, U.K. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 12: 153-66. PMID 3406459 DOI: 10.1016/0167-8140(88)90169-7  0.461
1988 Joiner MC, Johns H. Renal Damage in the Mouse: The Response to Very Small Doses per Fraction Radiation Research. 114: 385. DOI: 10.2307/3577233  0.497
1987 Joiner MC. Extension of the reciprocal dose analysis to the case of multiple fractions plus top-up. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 7: 349-51. PMID 3809594 DOI: 10.1016/S0167-8140(86)80065-2  0.424
1987 Carl UM, McNally NJ, Joiner MC. The effect of mixed fractionation with X rays and neutrons on tumour growth delay and skin reactions in mice. The British Journal of Radiology. 60: 583-8. PMID 3620817 DOI: 10.1259/0007-1285-60-714-583  0.3
1987 Joiner MC. The design and interpretation of 'top-up' experiments to investigate the effects of low radiation doses. International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine. 51: 115-30. PMID 3492459 DOI: 10.1080/09553008714550551  0.539
1986 Joiner MC, Denekamp J, Maughan RL. The use of 'top-up' experiments to investigate the effect of very small doses per fraction in mouse skin. International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine. 49: 565-80. PMID 3485598 DOI: 10.1080/09553008514552811  0.514
1986 Joiner MC, Michael BD. A cautionary note on the use of ionization chambers for radiation dosimetry in different gas mixtures. International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine. 49: 163-4. PMID 3484466 DOI: 10.1080/09553008514552331  0.341
1986 Joiner MC, Denekamp J. Evidence for a constant repair capacity over 20 fractions of X-rays. International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine. 49: 143-50. PMID 3484465 DOI: 10.1080/09553008514552311  0.454
1984 Joiner MC, Bremner JC, Denekamp J. The therapeutic advantage of combined X-rays and melphalan. International Journal of Radiation Oncology, Biology, Physics. 10: 385-92. PMID 6706732 DOI: 10.1016/0360-3016(84)90059-2  0.363
1984 Joiner MC, Bremner JC, Denekamp J, Maughan RL. The interaction between X-rays and 3 MeV neutrons in the skin of the mouse foot. International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine. 46: 625-38. PMID 6335141 DOI: 10.1080/09553008414551811  0.424
1984 Denekamp J, Joiner MC, Maughan RL. Neutron RBEs for Mouse Skin at Low Doses per Fraction Radiation Research. 98: 317. DOI: 10.2307/3576239  0.52
1983 Fowler JF, Joiner MC, Williams MV. Low doses per fraction in radiotherapy: a definition for "flexure dose". The British Journal of Radiology. 56: 599-601. PMID 6871614 DOI: 10.1259/0007-1285-56-668-599  0.413
1983 Joiner MC, Maughan RL, Fowler JF, Denekamp J. The RBE for Mouse Skin Irradiated with 3-MeV Neutrons: Single and Fractionated Doses Radiation Research. 95: 130. DOI: 10.2307/3576078  0.445
1982 Denekamp J, Joiner MC. The potential benefit from a perfect radiosensitizer and its dependence on reoxygenation. The British Journal of Radiology. 55: 657-63. PMID 7127007 DOI: 10.1259/0007-1285-55-657-657  0.353
1981 Denekamp J, McNally NJ, Fowler JF, Joiner MC. Misonidazole in fractionated radiotherapy: are many small fractions best? The British Journal of Radiology. 53: 981-90. PMID 7426922 DOI: 10.1259/0007-1285-53-634-981  0.425
Show low-probability matches.